XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash Flows from Operating Activities:    
Net income (loss) $ (47,534) $ (21,945)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 325 647
(Gain) loss on extinguishment of debt (53) 27,479
Gain on derecognition of accrued expenses and purchase price guarantee 0 (8,300)
(Gain) loss from change in fair value of hybrid financial instruments 46,959 (11,958)
(Gain) loss from change in fair value of derivative liability - warrants (3,503) (5,818)
(Gain) loss from change in fair value of derivative liability - Series C and D preferred stock and debentures 4,769 13,262
Interest expense related to convertible debt 0 4,407
Stock-based compensation expense 1 15
Impairment loss on cash surrender value of life insurance policy 0 527
Changes in operating assets and liabilities:    
Trade accounts receivable (386) 107
Prepaid expenses and other assets 59 (26)
Accounts payable and accrued expenses 52 (243)
Deferred revenue and customer prepayments (1,225) 469
Net cash used in operating activities (536) (1,377)
Cash Flows from Investing Activities:    
Acquisition of property and equipment 0 (5)
Net cash used in investing activities 0 (5)
Cash Flows from Financing Activities:    
Borrowing under short-term notes payable 110 110
Payments on short-term notes payable (27) 0
Borrowing under convertible debt instruments 0 2,500
Net cash provided by financing activities 83 2,610
Effect of exchange rate changes on cash (1) 18
Net change in cash and cash equivalents (454) 1,246
Cash and cash equivalents, beginning of period 611 30
Cash and cash equivalents, end of period 157 1,276
Supplemental cash flow information:    
Series C preferred stock converted to common stock 24 878
Series D preferred stock converted to common stock 0 2,342
Convertible debentures converted to common stock 4,233 13,825
Deemed dividend on Series C preferred stock issued 16 0
Deemed dividend on convertible debentures converted $ 726 $ 0